News

China Nuokang has posted a net income of RMB17.07m, or RMB0.11 per diluted share, compared to RMB11.19m, or RMB0.05 per diluted share, for the prior year period. Operating

The sales for Protidiet increased compared to the same quarter of 2009 due to the higher demand for Ranaz’s products in US. The sales for ProtiLife decreased, compared

Sinovac said that, as part of the bidding process, the Beijing CDC will evaluate potential suppliers and assigns scores for different factors, including product quality, service and price.

The option to license the breast cancer vaccine technology can be exercised after Phase I clinical trials under terms agreed between Mayo Clinic and TapImmune. Reportedly, upon IND

According to Amgen, Prolia’s approval is based on a pivotal three-year Phase 3 study involving 7,808 postmenopausal women with osteoporosis. Amgen claimed that Prolia, the first and only

YAZ is a progesterone and estrogen combination birth control pill. Yaz is used for preventing pregnancy. Teva Pharma has claimed that, as the first company to file an

Scientists at Alnylam and collaborators from Mount Sinai School of Medicine have published the research findings in the journal Proceedings of the National Academy of Sciences (PNAS). Reportedly,

Illumina said that the array provides up to 50% more coverage of human genome variation. The Omni2.5 delivers genome coverage for both SNP and copy number variation (CNV)

Mr Weyer will lead Amylin’s R&D organization, focusing on expanding opportunities with the company’s existing diabetes products, advancing the obesity and early diabetes pipeline, and driving research programs